Christoph Meisner

3.5k total citations
53 papers, 2.2k citations indexed

About

Christoph Meisner is a scholar working on Surgery, Oncology and Cancer Research. According to data from OpenAlex, Christoph Meisner has authored 53 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 12 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Christoph Meisner's work include Breast Cancer Treatment Studies (9 papers), Cancer Treatment and Pharmacology (6 papers) and Vestibular and auditory disorders (5 papers). Christoph Meisner is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Cancer Treatment and Pharmacology (6 papers) and Vestibular and auditory disorders (5 papers). Christoph Meisner collaborates with scholars based in Germany, Netherlands and United States. Christoph Meisner's co-authors include Christoph Thomssen, Nadia Harbeck, Manfred Schmitt, Fred C.G.J. Sweep, Gerd Döring, Michael Untch, F. Jänicke, Stefan K. Plontke, Martin Stern and H. K. Selbmann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

Christoph Meisner

50 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christoph Meisner Germany 24 492 399 391 364 303 53 2.2k
Jacky Y. Suen Australia 27 203 0.4× 337 0.8× 628 1.6× 135 0.4× 219 0.7× 118 2.9k
Staffan Edström Sweden 27 219 0.4× 481 1.2× 380 1.0× 388 1.1× 199 0.7× 79 2.2k
Yukari Uemura Japan 22 121 0.2× 462 1.2× 288 0.7× 424 1.2× 249 0.8× 160 2.1k
Dong Choon Park South Korea 25 93 0.2× 290 0.7× 241 0.6× 254 0.7× 374 1.2× 109 1.8k
Shahrad R. Rassekh Canada 25 167 0.3× 167 0.4× 587 1.5× 863 2.4× 231 0.8× 108 2.7k
Anja Victor Germany 21 176 0.4× 331 0.8× 242 0.6× 180 0.5× 580 1.9× 53 1.7k
Shue‐Fen Luo Taiwan 37 363 0.7× 476 1.2× 971 2.5× 249 0.7× 603 2.0× 101 3.7k
Ísleifur Ólafsson Iceland 29 425 0.9× 217 0.5× 702 1.8× 146 0.4× 244 0.8× 68 3.0k
David R. Edelstein United States 23 134 0.3× 740 1.9× 221 0.6× 254 0.7× 80 0.3× 43 2.1k
Xu Zhang China 30 252 0.5× 348 0.9× 833 2.1× 300 0.8× 536 1.8× 162 2.7k

Countries citing papers authored by Christoph Meisner

Since Specialization
Citations

This map shows the geographic impact of Christoph Meisner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Meisner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Meisner more than expected).

Fields of papers citing papers by Christoph Meisner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Meisner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Meisner. The network helps show where Christoph Meisner may publish in the future.

Co-authorship network of co-authors of Christoph Meisner

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Meisner. A scholar is included among the top collaborators of Christoph Meisner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Meisner. Christoph Meisner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mürdter, Thomas E., Werner Schroth, Matthew P. Goetz, et al.. (2025). Supplementation of Tamoxifen with Low-Dose Endoxifen in Patients with Breast Cancer with Impaired Tamoxifen Metabolism (TAMENDOX): A Randomized Controlled Phase I/II Trial. Clinical Cancer Research. 31(23). 4903–4911.
2.
Thomssen, Christoph, Martina Vetter, Eva Johanna Kantelhardt, et al.. (2023). Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group. Cancers. 15(5). 1580–1580.
3.
Henes, Jörg, Sebastian Saur, David M. Kofler, et al.. (2022). Tocilizumab for the Treatment of Familial Mediterranean Fever—A Randomized, Double-Blind, Placebo-Controlled Phase II Study. Journal of Clinical Medicine. 11(18). 5360–5360. 12 indexed citations
4.
Plontke, Stefan K., et al.. (2022). Efficacy and safety of systemic, high-dose glucocorticoid therapy for idiopathic sudden sensorineural hearing loss. HNO. 70(S2). 30–44. 6 indexed citations
5.
Albers, Peter, Thomas Wiegel, Heinz Schmidberger, et al.. (2020). Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial. World Journal of Urology. 39(1). 65–72. 2 indexed citations
6.
Häske, David, Bernd W. Böttiger, Bertil Bouillon, et al.. (2017). Analgesia in Patients with Trauma in Emergency Medicine A Systematic Review and Meta-analysis. Deutsches Ärzteblatt international. 114(46). 785. 20 indexed citations
7.
Weiß, Daniel, Margarete Teresa Walach, Christoph Meisner, et al.. (2013). Nigral stimulation for resistant axial motor impairment in Parkinson’s disease? A randomized controlled trial. Brain. 136(7). 2098–2108. 155 indexed citations
8.
9.
Döring, Gerd, et al.. (2007). A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients. Proceedings of the National Academy of Sciences. 104(26). 11020–11025. 135 indexed citations
10.
Filho, Luiz Vicente F. da Silva, Adriana Fumie Tateno, Doroti de Oliveira Garcia, et al.. (2007). The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosis. Pediatric Pulmonology. 42(10). 938–944. 32 indexed citations
11.
Sousa, Sílvia A., Martina Ulrich, Alessandra Bragonzi, et al.. (2007). Virulence of Burkholderia cepacia complex strains in gp91phox−/− mice. Cellular Microbiology. 9(12). 2817–2825. 53 indexed citations
12.
Plontke, Stefan K., Michael Bauer, & Christoph Meisner. (2007). Comparison of Pure-Tone Audiometry Analysis in Sudden Hearing Loss Studies. Otology & Neurotology. 28(6). 753–763. 48 indexed citations
13.
14.
15.
Klump, Bodo, et al.. (2005). Determinants of Life Satisfaction in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 11(3). 272–286. 108 indexed citations
16.
Schwab, Matthias, Ernst‐Ulrich Griese, Claudia Marx, et al.. (2002). Visual disorders associated with omeprazole and their relation to CYP2C19 polymorphism. Pharmacogenetics. 12(1). 73–75. 13 indexed citations
17.
Selbmann, H. K., et al.. (2002). Effekte einer regionalen Intervention zur Förderung der Implementierung von Asthma-Leitlinien. Das Gesundheitswesen. 64(5). 235–241. 2 indexed citations
18.
Schroeder, Stephen, Thomas Flohr, Andreas F. Kopp, et al.. (2001). Accuracy of Density Measurements Within Plaques Located in Artificial Coronary Arteries by X-Ray Multislice CT: Results of a Phantom Study. Journal of Computer Assisted Tomography. 25(6). 900–906. 78 indexed citations
19.
Bokemeyer, Carsten, Christian Kollmannsberger, Christoph Meisner, et al.. (1999). First-Line High-Dose Chemotherapy Compared With Standard-Dose PEB/VIP Chemotherapy in Patients With Advanced Germ Cell Tumors: A Multivariate and Matched-Pair Analysis. Journal of Clinical Oncology. 17(11). 3450–3456. 110 indexed citations
20.
Karsch, Karl R., David P. Foley, Eulogio Garcı́a, et al.. (1996). Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Journal of the American College of Cardiology. 28(6). 1437–1443. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacky Y. Suen Breakdown of academic impact, for papers by Staffan Edström Breakdown of academic impact, for papers by Yukari Uemura Breakdown of academic impact, for papers by Dong Choon Park Breakdown of academic impact, for papers by Shahrad R. Rassekh Breakdown of academic impact, for papers by Anja Victor Breakdown of academic impact, for papers by Shue‐Fen Luo Breakdown of academic impact, for papers by Ísleifur Ólafsson Breakdown of academic impact, for papers by David R. Edelstein Breakdown of academic impact, for papers by Xu Zhang
Rankless by CCL
2026